Additional file 5 of TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

Additional file 5 of TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

Additional file 5. Appendix 2. Summary statistics for all tested small RNA features in sequencing data (sorted by letozole/bevacizumab responder P).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vaklavas, Christos, Roberts, Brian, Varley, Katherine, Lin, Nancy, Minetta Liu, Rugo, Hope, Puhalla, Shannon, Nanda, Rita, Storniolo, Anna, Carey, Lisa, Saleh, Mansoor, Yufeng Li, Delossantos, Jennifer, Grizzle, William, LoBuglio, Albert, Myers, Richard, Forero-Torres, Andres
Format: Dataset
Sprache:eng
Schlagworte:
Cancer
Cell Biology
FOS: Biological sciences
FOS: Mathematics
Mathematical Sciences not elsewhere classified
Molecular Biology
Physiology
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Additional file 5. Appendix 2. Summary statistics for all tested small RNA features in sequencing data (sorted by letozole/bevacizumab responder P).
DOI:10.6084/m9.figshare.11870217